References of "Lancellotti, Patrizio"
     in
Bookmark and Share    
Peer Reviewed
See detailPoster session 5: Friday 5 December 2014, 14:00-18:00Location: Poster area.
Henri, C.; DULGHERU, Raluca Elena ULg; Magne, J. et al

Poster (2014, December)

Detailed reference viewed: 29 (10 ULg)
Peer Reviewed
See detailPoster session 3: Thursday 4 December 2014, 14:00-18:00Location: Poster area.
Gabriels, C.; LANCELLOTTI, Patrizio ULg; Van De Bruaene, A. et al

Poster (2014, December)

Detailed reference viewed: 16 (5 ULg)
Peer Reviewed
See detailPoster session 1: Wednesday 3 December 2014, 09:00-16:00Location: Poster area.
Romano, G.; D'ancona, G.; Pilato, G. et al

Poster (2014, December)

Detailed reference viewed: 16 (6 ULg)
Peer Reviewed
See detailOral Abstract session: Stress echo in clinical practice: Friday 5 December 2014, 08:30-10:00Location: Agora.
Magne, J.; Donal, E.; Dulgheru, R. et al

Conference (2014, December)

Detailed reference viewed: 16 (1 ULg)
Peer Reviewed
See detailPoster session 4: Friday 5 December 2014, 08:30-12:30Location: Poster area.
Uejima, T.; Itatani, K.; Nakatani, S. et al

Poster (2014, December)

Detailed reference viewed: 15 (2 ULg)
Peer Reviewed
See detailClub 35 Poster session 2: Thursday 4 December 2014, 08:30-18:00Location: Poster area.
Voilliot, D.; Magne, Jm; DULGHERU, Raluca Elena ULg et al

Poster (2014, December)

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailRecommandations européennes concernant la prise en charge de l'embolie pulmonaire.
MELISSOPOULOU, Maria ULg; ANCION, Arnaud ULg; LANCELLOTTI, Patrizio ULg

in Revue Medicale de Liege (2014), 69(11), 594-599

Detailed reference viewed: 74 (14 ULg)
Full Text
Peer Reviewed
See detailL'image du mois : Echocardiographie tridimensionnelle : une vue presque chirurgicale (2014).
JOACHIM, Sabrina ULg; NYSSEN, Astrid ULg; Henri, Christine et al

in Revue Médicale de Liège (2014), 69(10), 525

Detailed reference viewed: 19 (0 ULg)
Full Text
Peer Reviewed
See detailLe médicament du mois Combinaison fixe périndopril-indapamide-amlodipine (Triplixam®) pour le traitement de l’hypertension artérielle
SCHEEN, André ULg; LANCELLOTTI, Patrizio ULg; KRZESINSKI, Jean-Marie ULg

in Revue Médicale de Liège (2014), 69(10), 565-570

Triplixam® is a fixed dose combination of three well known antihypertensive agents, with complementary activities, to control blood pressure in patients with arterial hypertension : perindopril, an ... [more ▼]

Triplixam® is a fixed dose combination of three well known antihypertensive agents, with complementary activities, to control blood pressure in patients with arterial hypertension : perindopril, an angiotensin converting enzyme inhibitor, indapamide, un diuretic whith thiazide-like effects but also specific properties, and amlodipine, a long-acting calcium antagonist of the dihydropyridine family. The potential synergic action allows better control of blood pressure with once daily administration, while limiting the incidence of adverse events. Various presentations with different dosages are available to facilitate individualized therapy. Warnings and precautions for use of every molecule should of course be respected. Such a fixed dose combination should contribute to limit clinical inertia and to improve therapeutic compliance. [less ▲]

Detailed reference viewed: 266 (4 ULg)
Full Text
Peer Reviewed
See detail2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
Elliott, Perry M.; Anastasakis, Aris; Borger, Michael A. et al

in European heart journal (2014), 35(39), 2733-79

Detailed reference viewed: 35 (0 ULg)
Full Text
Peer Reviewed
See detailESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
Ryden, Lars; Grant, Peter J.; Anker, Stefan D. et al

in Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease (2014), 11(3), 133-73

Detailed reference viewed: 24 (1 ULg)
Full Text
Peer Reviewed
See detail2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.
Brignole, Michele; Auricchio, Angelo; Baron-Esquivias, Gonzalo et al

in Revista espanola de cardiologia (English ed.) (2014), 67(1), 58

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailRecommandations européennes pour la prise en charge des cardiopathies congénitales complexes de l'adulte
MILTNER, Béatrice ULg; LANCELLOTTI, Patrizio ULg; SEGHAYE, Marie-Christine ULg

in Revue Médicale de Liège (2014), 69(1), 16-25

THe number of patients with Grown-Up Congenital Heart disease (GUCH) consulting adult cardiologists is steadily increasing. These patients have either a non-diagnosed congenital heart disease revealed at ... [more ▼]

THe number of patients with Grown-Up Congenital Heart disease (GUCH) consulting adult cardiologists is steadily increasing. These patients have either a non-diagnosed congenital heart disease revealed at adulthood, or a diagnosed congenital heart disease for which one or multiple interventions have possibly been performed during childhood. In this article, we summarize the recommendations of the European Society of Cardiology of 2010 for complex congenital heart disease. [less ▲]

Detailed reference viewed: 122 (6 ULg)
Full Text
Peer Reviewed
See detailLa prevention des maladies cardiovasculaires est-elle encore utile chez la personne agee? Focus sur les antiagregants et les hypolipemiants.
RADERMECKER, Régis ULg; Lancellotti, Patrizio ULg

in Revue medicale de Liege (2014), 69(5-6), 318-22

The increase in life expectancy raises the difficult question of the most appropriate preventive medical therapy in the elderly. Indeed, beyond physiological age, comorbidities, contraindications and life ... [more ▼]

The increase in life expectancy raises the difficult question of the most appropriate preventive medical therapy in the elderly. Indeed, beyond physiological age, comorbidities, contraindications and life expectancy should be considered before starting any treatment. Cardiovascular disease remains the leading cause of death in our country, especially in the elderly. A preventive treatment aiming at controlling cardiovascular risk factors should be initiated based on the currently available evidence. We shall briefly discuss the value of cardiovascular prevention in the elderly and specifically focus on the use (or not) of antiplatelet agents and lipid-lowering drugs (i.e. statins). [less ▲]

Detailed reference viewed: 75 (8 ULg)
See detailTHE EACVI ECHOCARDIOGRAPHY TEXTBOOK
LANCELLOTTI, Patrizio ULg; HABIB, Gilbert; BADANO, L. et al

Book published by Oxford University Press (2014)

Detailed reference viewed: 17 (0 ULg)
See detailTHE EACVI HANDBOOK OF ECHOCARDIOGRAPHY
LANCELLOTTI, Patrizio ULg; COSYSNS, B.

Book published by Oxford University Press (2014)

Detailed reference viewed: 10 (0 ULg)